Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
Go back to Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 45.68 +1.48 (3.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.20 | 52 Week High | $0.15 | |||
| Open | $44.39 | 52 Week Low | $0.15 | |||
| Day High | $45.68 | P/E | N/A | |||
| Day Low | $44.28 | EPS | $0.00 | |||
| Volume | 17,407 | |||||
